The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Aliev N.A.

Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow, Russia

Aliev Z.N.

Clinical characteristics and treatment of depersonalization disorders

Authors:

Aliev N.A., Aliev Z.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(6): 97‑101

Views: 10975

Downloaded: 292

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Aliev NA, Aliev ZN. Clinical characteristics and treatment of depersonalization disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(6):97‑101. (In Russ.)

 
МСФ на ЯМ
Close metadata
Recommended articles:
Promising approaches to the pathogenetic therapy of amyotrophic late­ral scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):13-21
Long-term follow-up of adult patients with serial and status course of epileptic seizures. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):63-68
Effi­cacy and safety of choline alfo­scerate in the preventive therapy of deme­ntia in elde­rly patients with Mild Cognitive Impairment: a three-year prospective comparative study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):92-99
B vita­mins and diseases of the peri­pheral nervous system. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):75-82
Russian multiple-center study of effi­cacy and safety of cyclobenzaprine for nonspecific neck and low back pain. Russian Journal of Pain. 2024;(1):27-33
Successful combinations of drug and non-drug therapy for low back pain. Russian Journal of Pain. 2024;(1):57-67
Traumatic damage to the diaphragm in children. Piro­gov Russian Journal of Surgery. 2024;(4):64-68
Use of systemic steroids in hospitalized patients with COVID-19. Russian Journal of Preventive Medi­cine. 2024;(5):75-80
Our expe­rience in the treatment of congenital nasal median hete­rotopias in children and an overview of various treatment tactics. Russian Bulletin of Otorhinolaryngology. 2024;(2):28-32
Clinical and anatomical rationale for the effe­ctiveness of treatment of phle­gmon of the floor of the oral cavity and deep cellular spaces of the neck complicated with sepsis. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(2):19-25

Keywords:

depersonalization syndrom
clinical characteristics
treatment

Authors:

Aliev N.A.

Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow, Russia

Aliev Z.N.

List of references:

  1. Akhapkina M.V.Psikhopatologiya i klinika depersonalizatsionnykh rasstroistv pri shizofrenii: Avtoref. dis. ... kand. med. nauk. M 1993; 22.
  2. Zhmurov V.A.Psikhopatologiya. M: Meditsinskaya kniga, Nizhnii Novgorod 2002; 668.
  3. Kafarov T.A.Dinamika rasstroistv samosoznaniya v klinike shizofrenii. Baku 1998; 26.
  4. Kafarov T.A.Psikhopatologiya samosoznaniya v patokineze shizofrenii: Avtoref. dis. ... d-ra med. nauk. Baku 2000; 285.
  5. Klinicheskaya psikhiatriya. Per. s angl. Glavnyi redaktor T.B. Dmitrieva M: GEOTAR 1998; 505.
  6. Myasishchev V.N.Soznanie kak edinstvo otrazheniya deistvitel'nosti i otnosheniyakh k nei cheloveka. Problemy soznaniya. M 1966; 126-132.
  7. Nosachev G.N.Endogennye depressii i depersonalizatsiya. M 1989.
  8. Nosachev G.N.Endogennye depressii: sistematika, psikhopatologiya, terapiya: Avtoref. dis. ... d-ra med. nauk. M 1991.
  9. Nosachev G.N., Baranov B.C.Znachenie narushenii samosoznaniya pri endogennykh psikhozakh dlya reabilitatsionnykh meropriyatii. Nevrologicheskii vestnik 1994; XXVI: 3-4: 24-28.
  10. Nuller Yu.L.Depressiya i depersonalizatsiya. L: Meditsina 1981; 207.
  11. Nuller Yu.L.Depersonalizatsiya: patogeneticheskie mekhanizmy i terapiya. KhIII s''ezd psikhiatrov Rossii 10-13.10.2000 g. Materialy. M 2000; 190.
  12. Nuller Yu.L., Mikhalenko I.N.Affektivnye psikhozy. L: Meditsina 1988; 264.
  13. Psikhiatriya. Natsional'noe rukovodstvo. Glavnye redaktory: T.B. Dmitrieva i dr. M: GEOTAR 2009; 1000.
  14. Semenov S.F.O klinicheskikh proyavleniyakh rasstroistva samosoznaniya. Problemy soznaniya. Materialy simpoziuma. M 1966; 240-247.
  15. Sergeev I.I., Basova A.L.Bredovaya depersonalizatsiya. M: Tsifrovichel 2009; 192.
  16. Smulevich A.B., Vorob'ev V.A.Depersonalizatsiya, kliniko-psikhopatologicheskie aspekty. Zhurn nevropatol i psikhiatr 1973; 8: 1242-1252.
  17. Snezhnevskii A.V.Obshchaya psikhopatologiya: Kurs lektsii. Valdai 1970; 178.
  18. Snezhnevskii A.V.Klinicheskaya psikhopatologiya V kn.: Rukovodstvo po psikhiatrii. M 1983; 1: 16-96.
  19. Shmar'yan A.S.K voprosu o psikhofiziologicheskikh zakonomernostyakh depersonalizatsii. Sovetskaya nevropatologiya, psikhiatriya i psikhogigiena 1934; 3: 6: 67-96.
  20. Shogam A.N.Problema soznaniya i psikhologicheskaya model' lichnosti. Problemy soznaniya. Materialy simpoziuma. M 1966; 195-210.
  21. Yaspers K.Obshchaya psikhopatologiya. Per. s nem. M: Praktika 1997; 1056.
  22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text revised. Washington, DC 2000.
  23. Anand A., Charney D.S., Oren D.A. et al.Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 2000; 57: 270-276.
  24. Black D.W., Wojcieszek J.Depersonalization syndrome induced by fluoxetine. Psychosomatics 1991; 32: 468-469.
  25. Bohus M.J., Landwehrmeyer G.V., Stiglmayr S.E. et al.Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial. J Clin Psychiatry 1999; 60: 598-603.
  26. Brauer R., Harrow M., Tucker G.J.Depersonalisation phenomena in psychiatric patients. Brit J Psychiatry 1970; 117: 509-515.
  27. British Medical Association and Royal Pharmaceutical Society of Great Britain British National Formulary. London: BMJ Books and Pharmaceutical Press 2004.
  28. Danel T., Leys D., Destee A.Anosognosia and depression. Neurology 1991; 41: 6: 951.
  29. Dugas L., Moutier F.La dépersonnalisation. Paris 1911; 223.
  30. Haug K.Depersonslisasion and verwandte Erscheinungen. Hand. Geisteskr. Hrsg. V.O. Bumke. Erganz. Berlin 1939; 1: 134-204.
  31. Hollander E., Liebowitz M.R., DeCaria C. et al.Treatment of depersonalization with serotonin reuptake blockers. J Clin Psychopharmacology 1990; 10: 200-203.
  32. Hunter E.C., Sierra M., David A.S.The epidemiology of depersonalisation and derealisation. A systematic review. Soc Psychiatry Psychiatr Epidemiol 2004; 39: l: 9-18.
  33. Medford N., Sierra M., Baker D., David A.S.Understanding and treating depersonalisation disorder. Adv Psychiatric Treatment 2005; 11: 92-100.
  34. Michal M., Beutel M.E., Grobe T.G.How often is the Depersonalization-Derealization Disorder (ICD-10: F48.1) diagnosed in the outpatient health-care service? Z Psychosom Med Psychother 2010; 56: 1: 74-83.
  35. Michal M., Wiltink J., Subic-Wrana C. et al.Prevalence, correlates, and predictors of depersonalization experiences in the German general population. J Nerv Ment Dis 2009; 197: 7: 499-506.
  36. Nuller Y.L.Depersonalisazion - symptoms, meaning, therapy. Acta Psychiatr Scand 1982; 66: 451-458.
  37. Nuller Y.L., Morozova M.G., Kushnir O.N., Hamper N.Effect of naloxone therapy on depersonalization: a pilot study. J Psychopharmacol 2001; 15: 93-95.
  38. Ratliff N.B., Kerski D.Depersonalization treated with fluoxetine (letter). Am J Psychiatry 1995; 152: 1689-1690.
  39. Sachdev P.Citalopram-Clonazepam combination for primary depersonalization disorder: a case report. Austr N Z J Psychiatry 2002; 36: 424-425.
  40. Sarkar J., Jones N., Sullivan G.A case of depersonalization-derealization syndrome during treatment with quetiapine. J Psychopharmacol 2001; 15: 209-211.
  41. Sierra M., Berrios G.E.A case of depersonalization. Hist Psychiatry 1996: 7: 451-461.
  42. Sierra M., Berrios G.E.The Cambridge Depersonalization Scale: a new instrument for the measurement of depersonalization. Psychiatry Res 2000; 93: 153-164.
  43. Sierra M., Phillips M.L., Ivin G. et al.A placebo-controlled crossover trial of lamotrigine in depersonalization disorder. J Psychopharmacology 2003; 17: 103-105.
  44. Sierra M., Baker D., Medford N. et al.Lamotrigine as an Add-on Treatment for Depersonalization Disorder: A Retrospective Study of 32 Cases. J Clin Neuropharmacol 2006; 29: 253-258.
  45. Sierra M.Depersonalization disorder: pharmacological approaches. Exp Rev Neurotherapeutics 2008; 8: 1: 19-26.
  46. Sierra M.Depersonalization: A New Look at a Neglected Syndrom. New York: Cambridge University Press 2009.
  47. Simeon D., Hollander E., Stein D.J. et al.Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. Psychiat Res 1995; 58: 161-164.
  48. Simeon D., Stein D.J., Hollander E.Treatment of depersonalization disorder with clomipramine. Biol Psychiat1998; 44: 302-303.
  49. Simeon D.Depersonalisation disorder: a contemporary overview. CNS Drugs 2004; 18: 6: 343-354.
  50. Stein M.B., Uhde T.W.Depersonalization disorder: effects of caffeine and response to pharmacotherapy. Biol Psychiat 1989; 26: 315-320.
  51. Strohle A., Kumpfel T., Sonntag A.Paroxetine for depersonalization associated with multiple sclerosis. Am J Psychiat 2000; 157: 150.
  52. Walsh S.L., Strain E.C., Abreu M.E. et al.Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berlin) 2001; 157: 151-162.
  53. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO 1992.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.